Cargando…

A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma

BACKGROUND: The blood-brain barrier (BBB) is a major limiting factor for drug delivery in brain tumors. Laser interstitial thermal therapy (LITT) disrupts the peritumoral BBB. In this study, we examine survival in patients with recurrent glioblastoma (GBM) treated with LITT followed by low-dose doxo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butt, Omar H, Zhou, Alice Y, Huang, Jiayi, Leidig, William A, Silberstein, Alice E, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Liu, Jingxia, Talcott, Grayson, Nakiwala, Ruth, Shimony, Joshua S, Kim, Albert H, Leuthardt, Eric C, Tran, David D, Campian, Jian L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694207/ https://www.ncbi.nlm.nih.gov/pubmed/34988450 http://dx.doi.org/10.1093/noajnl/vdab164

Ejemplares similares

Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma
por: Butt, Omar H, et al.
Publicado: (2022)

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab
por: Hwang, Helen, et al.
Publicado: (2022)

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021)

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
por: Khaddour, Karam, et al.
Publicado: (2020)

A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma
por: Ghosh, Subhajit, et al.
Publicado: (2023)

Predicting survival in glioblastoma with multimodal neuroimaging and machine learning
por: Luckett, Patrick H., et al.
Publicado: (2023)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Selective interstitial doxorubicin for recurrent glioblastoma
por: Matcovschii, Valerii, et al.
Publicado: (2019)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

Magnetic Resonance Imaging-Guided Focused Laser Interstitial Thermal Therapy for Intracranial Lesions: Single-Institution Series
por: Hawasli, Ammar H., et al.
Publicado: (2013)

Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
por: Leuthardt, Eric C., et al.
Publicado: (2016)

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
por: Khaddour, Karam, et al.
Publicado: (2023)

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
por: Damato, Anna R, et al.
Publicado: (2021)

Glioblastoma Treated With Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy: Safety, Efficacy, and Outcomes
por: Kamath, Ashwin A, et al.
Publicado: (2019)

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2023)

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma
por: de Groot, John F, et al.
Publicado: (2022)

Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy
por: Salehi, Afshin, et al.
Publicado: (2018)

PARP inhibition and immunotherapy: a promising duo in fighting cancer
por: Phillipps, Jordan, et al.
Publicado: (2023)

Machine Learning Analytics of Resting-State Functional Connectivity Predicts Survival Outcomes of Glioblastoma Multiforme Patients
por: Lamichhane, Bidhan, et al.
Publicado: (2021)

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry
por: Galdieri, Luciano, et al.
Publicado: (2021)

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
por: Johanns, Tanner M., et al.
Publicado: (2019)

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
por: Khaddour, Karam, et al.
Publicado: (2022)

Functional connectivity within glioblastoma impacts overall survival
por: Daniel, Andy G S, et al.
Publicado: (2020)

A Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy
por: Leuthardt, Eric C., et al.
Publicado: (2016)

Glioblastoma induces whole-brain spectral change in resting state fMRI: Associations with clinical comorbidities and overall survival
por: Park, Ki Yun, et al.
Publicado: (2023)

Prolonged survival after laser interstitial thermal therapy in glioblastoma
por: Khan, A. Basit, et al.
Publicado: (2021)

Laser Interstitial Thermal Therapy in Grade 2/3 IDH1/2 Mutant Gliomas: A Preliminary Report and Literature Review
por: Johnson, Gabrielle W., et al.
Publicado: (2022)

Prediction of recurrent glioblastoma after laser interstitial thermal therapy: The role of diffusion imaging
por: Mahammedi, Abdelkader, et al.
Publicado: (2019)

Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA
por: Pacia, Christopher P., et al.
Publicado: (2022)

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
por: Ansstas, George, et al.
Publicado: (2016)

Structural gray matter alterations in glioblastoma and high-grade glioma—A potential biomarker of survival
por: Lamichhane, Bidhan, et al.
Publicado: (2023)

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
por: Sener, Ugur, et al.
Publicado: (2022)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
por: Ghaferi, Mohsen, et al.
Publicado: (2022)

Combined Effects of Doxorubicin and Temozolomide in Cultured Glioblastoma Cells
por: BALOI, CARINA, et al.
Publicado: (2022)

Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
por: Ziganshina, Albina Y., et al.
Publicado: (2023)

Laser Interstitial Thermal Therapy in Patients with Newly Diagnosed Glioblastoma: A Systematic Review
por: Viozzi, Ilaria, et al.
Publicado: (2021)

The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study
por: Mohammadi, Alireza M, et al.
Publicado: (2014)

Therapeutic enhancement of blood–brain and blood–tumor barriers permeability by laser interstitial thermal therapy
por: Salehi, Afshin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sj6p7msvb8d84p8i2f6o8i8ai9